Lucid Diagnostics (LUCD) Debt Ratio (2021)
Lucid Diagnostics' (LUCD) quarterly Debt Ratio came in at 6.8 in Q3 2021.
Lucid Diagnostics (LUCD) Debt Ratio (2021) Analysis & Trends
Lucid Diagnostics (LUCD) has 1 years of Debt Ratio data on file, last reported at 6.8 in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | 0.30 |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 0.31 |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 0.30 |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 0.28 |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 0.04 |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 0.27 |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 0.28 |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 0.18 |
| 10 | Lucid Diagnostics | 176.75 Mn | 143.35 Mn | 55,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 6.80 |